Global Cervical Dysplasia Diagnostic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431860
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • F. Hoffmann La-Roche Ltd.
  • Hologic, Inc.
  • OncoHealth Corporation
  • Other Notable Play
  • QIAGEN N.V.
  • MORE
Cervical Dysplasia Diagnostic Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025, the global cervical dysplasia diagnostic market was valued at US$ 437.3 Mn in 2016, and is expected to reach US$ 791.3 Mn by 2025, expanding at a CAGR of 6.5% from 2017 to 2025

Market Insights

Cervical dysplasia, also known as cervical intraepithelial neoplasia (CIN), causes abnormal cell growth that occurs on the epithelial lining of the cervix. It is the precancerous condition of the cervix which in an average of 10-15 years would progress to cervical cancer. It is common health problem observed in among women. WHO and national governments are taking initiatives for providing screening program and effective education to promote preventive practices among women. Annually around 250,000 to 1 million women in the U.S. are diagnosed with cervical dysplasia. The peak incidence in women ranges from age 25 - 35 and if not diagnosed or treated at the earliest may progress in 30-40% cases into invasive cancer. Cervical cancer is a global burden, especially in developing countries where it is the most common cause of preventable cancer-related mortality. Thus rising incidence of cervical dysplasia and advancement in diagnostic technology and treatment option are the key factors contributing the growth of cervical dysplasia diagnostic market.

The global cervical dysplasia diagnostic market is segmented by diagnosis type into diagnostic test and diagnostic devices. Diagnostic test types is further segmented into HPV test, pap smear test and biopsy.

As of the current market scenario, North America dominates the global cervical dysplasia diagnostic market followed by the Europe. Rise in incidence of cervical dysplasia, advancement in diagnostic technology, awareness about cervical cancer and available novel treatment option are some of the major factors driving the growth of cervical dysplasia diagnostic market in North America and Europe. Asia Pacific is the fastest growing regional market for cervical dysplasia with highest CAGR in the forecast period.

Market Competition Assessment

Key players in the global cervical dysplasia diagnostic market are Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann La-Roche Ltd., GlaxoSmithKline Plc, Helix BioPharma Corp., Hologic, Inc., Inovio Biomedical Corporation, Micromedic Technologies Ltd., OncoHealth Corporation, PDS Biotechnology Corporation, Photocure ASA, Quest Diagnostics, Inc., QIAGEN N.V. and others.

Key Market Movements:
  • Increase in incidence and mortality of cervical cancer is leading to global burden especially in developing countries. In developed countries government is taking initiatives for screening programs with goal of early diagnosis and treatment of cervical dysplasia which play pivotal role in growth of cervical dysplasia diagnostic market.
  • Advancement in diagnostic technology and novel drug treatment option available in market would further propel the growth of cervical dysplasia diagnostic market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • F. Hoffmann La-Roche Ltd.
  • Hologic, Inc.
  • OncoHealth Corporation
  • Other Notable Play
  • QIAGEN N.V.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Cervical Dysplasia Diagnostic Market Portraiture
2.1.1. Global Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2016
2.1.2. Global Cervical Dysplasia Diagnostic Market, by Geography, 2016

Chapter 3. Cervical Dysplasia Diagnostic: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Cervical Dysplasia Diagnostic Market, by Type, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Cervical Dysplasia Diagnostic Market, by Type
4.3. Diagnostic Test
4.3.1. HPV Test
4.3.2. Pap Smear Test
4.3.3. Biopsy
4.4. Diagnostic Device
4.4.1. Colposcopy

Chapter 5. Global Cervical Dysplasia Diagnostic Market, by Geography, 2015 - 2025 (US$ Mn)
5.1. Overview
5.2. North America Cervical Dysplasia Diagnostic Market Analysis, 2015 - 2025
5.2.1. North America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
5.2.2. North America Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.2.2.1. U.S.
5.2.2.1.1. U.S. Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.2.2.2. Canada
5.2.2.2.1. Canada Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.3. Europe Cervical Dysplasia Diagnostic Market Analysis, 2015 - 2025
5.3.1. Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
5.3.2. Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.3.2.1. U.K.
5.3.2.1.1. U.K. Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.3.2.2. Germany
5.3.2.2.1. Germany Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.3.2.3. Rest of Europe
5.3.2.3.1. Rest of Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.4. Asia Pacific Cervical Dysplasia Diagnostic Market Analysis, 2015 - 2025
5.4.1. Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
5.4.2. Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.4.2.1. Japan
5.4.2.1.1. Japan Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.4.2.2. China
5.4.2.2.1. China Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.4.2.3. Rest of Asia Pacific
5.4.2.3.1. Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.5. Latin America Cervical Dysplasia Diagnostic Market Analysis, 2015 - 2025
5.5.1. Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
5.5.2. Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.5.2.1. Brazil
5.5.2.1.1. Brazil Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.5.2.2. Mexico
5.5.2.2.1. Mexico Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.5.2.3. Rest of Latin America
5.5.2.3.1. Rest of Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.6. Middle East & Africa (MEA) Cervical Dysplasia Diagnostic Market Analysis, 2015 - 2025
5.6.1. MEA Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
5.6.2. MEA Cervical Dysplasia Diagnostic Market, by Region, 2015 - 2025 (US$ Mn)
5.6.2.1. GCC
5.6.2.1.1. GCC Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
5.6.2.2. Rest of MEA
5.6.2.2.1. Rest of MEA Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)

Chapter 6. Company Profiles
6.1. Abbott Laboratories
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Becton, Dickinson and company
6.3. F. Hoffmann La-Roche Ltd.
6.4. Hologic, Inc.
6.5. Micromedic Technologies Ltd.
6.6. OncoHealth Corporation
6.7. PDS Biotechnology Corporation
6.8. Quest Diagnostics, Inc.
6.9. QIAGEN N.V.
6.10. Other Notable Players

List of Figures
Fig. 1 Cervical Dysplasia: Market Segmentation
Fig. 2 Global Cervical Dysplasia Diagnostic Market Share, by Type, 2016 (US$ Mn)
Fig. 3 Global Cervical Dysplasia Diagnostic Market, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition, by Geography
Fig. 5 Market Competition Landscape, by Key Players, 2016
Fig. 6 Global Cervical Dysplasia Diagnostic Market, by HPV Test, 2015 - 2025 (US$ Mn)
Fig. 7 Global Cervical Dysplasia Diagnostic Market, by Pap Smear Test, 2015 - 2025 (US$ Mn)
Fig. 8 Global Cervical Dysplasia Diagnostic Market, by Biopsy, 2015 - 2025 (US$ Mn)
Fig. 9 Global Cervical Dysplasia Diagnostic Market, by Colposcopy, 2015 - 2025 (US$ Mn)
Fig. 10 U.S. Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 11 Canada Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 12 U.K. Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 13 Germany Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 14 Rest of Europe Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 15 Japan Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 16 China Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 17 Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 18 Brazil Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 19 Mexico Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 20 Rest of Latin America Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 21 GCC Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)
Fig. 22 Rest of Middle East and Africa Cervical Dysplasia Diagnostic Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 2 Global Cervical Dysplasia Diagnostic Market, by Treatment Type, 2015 - 2025 (US$ Mn)
Table 3 North America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 4 U.S. Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 5 Canada Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 6 North America Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 8 UK Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 9 Germany Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 10 Rest of Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 11 Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
Table 12 Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 13 Japan Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 14 China Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 15 Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 16 Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025(US$ Mn)
Table 17 Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025(US$ Mn)
Table 18 Brazil Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025(US$ Mn)
Table 19 Mexico America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025(US$ Mn)
Table 20 Rest of Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025(US$ Mn)
Table 21 Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 - 2025 (US$ Mn)
Table 22 Middle East and Africa Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 23 GCC Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 24 Rest of Middle East and Africa Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 - 2025 (US$ Mn)
Table 25 Middle East and Africa Cervical Dysplasia Diagnostic Market, by Region, 2015 - 2025 (US$ Mn)
Table 26 Abbott Laboratories: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 27 Becton, Dickinson and company: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 28 F. Hoffmann La-Roche Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 29 Hologic, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 30 Micromedic Technologies Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 31 OncoHealth Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 32 PDS Biotechnology Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 33 Quest Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 34 QIAGEN N.V.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Becton, Dickinson and company
  • F. Hoffmann La-Roche Ltd.
  • Hologic, Inc.
  • Micromedic Technologies Ltd.
  • OncoHealth Corporation
  • PDS Biotechnology Corporation
  • Quest Diagnostics, Inc.
  • QIAGEN N.V.
  • Other Notable Play
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll